A shape-controlled tuneable microgel platform to modulate angiogenic paracrine responses in stem cells

Biomaterials

Volumn 35, Issue 31, 2014, Pages 8757-8766

  Thomas, Dilip ^a   Fontana, Gianluca ^a   Chen, Xizhe ^a   Sanz Nogués, Clara ^a   Zeugolis, Dimitrios I ^a   Dockery, Peter ^a   O'Brien, Timothy ^a   Pandit, Abhay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Angiogenesis; Cell factories; Customised ECM matrices; Mesenchymal stem cells; Microgels

Indexed keywords

CELL CULTURE; CHEMICAL COMPOUNDS; REPAIR; STEM CELLS; TISSUE;

ANGIOGENESIS; CELL-FACTORIES; EXTRACELLULAR MATRIX MOLECULES; FUNCTIONAL IMPROVEMENTS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); MESENCHYMAL STEM CELL; MICRO-GELS; TISSUE-ENGINEERED CONSTRUCTS;

GELS;

COLLAGEN TYPE 1; BIOMATERIAL; GEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DENSITY; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HIND LIMB ISCHEMIA; IN VIVO STUDY; LIMB ISCHEMIA; MACROMOLECULE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TYMPANOSTOMY TUBE; VASCULAR SURGERY; ANGIOGENESIS; ANIMAL; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; GEL; HINDLIMB; HUMAN; ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PARACRINE SIGNALING; SURGERY; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELL SURVIVAL; COLLAGEN TYPE I; GELS; HINDLIMB; HUMANS; ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; TISSUE ENGINEERING;

EID: 84905510304     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.06.053     Document Type: Article

References (51)

1. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
2. Butler J.M., Kobayashi H., Rafii S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 2010, 10:1-9.
3. Read T.-A., Sorensen D.R., Mahesparan R., Enger P.O., Timpl R., Olsen B.R., et al. Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat Biotechnol 2001, 19:29-34.
4. Joki T., Machluf M., Atala A., Zhu J., Seyfried N.T., Dunn I.F., et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001, 19:35-39.
5. Peppas N.A., Hilt J.Z., Khademhosseini A., Langer R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater 2006, 18:1345-1360.
6. Khademhosseini A., Langer R. Microengineered hydrogels for tissue engineering. Biomaterials 2007, 28:5087-5092.
7. Hoffman A.S. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002, 54:3-12.
8. Lee K.Y., Mooney D.J. Hydrogels for tissue engineering. Chem Rev 2001, 101:1869-1879.
9. Köllmer M., Keskar V., Hauk T.G., Collins J.M., Russell B., Gemeinhart R.A. Stem cell-derived extracellular matrix enables survival and multilineage differentiation within superporous hydrogels. Biomacromolecules 2012, 13:963-973.
10. Hern D.L., Hubbell J.A. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 1998, 39:266-276.
11. Gaudet I.D., Shreiber D.I. Characterization of methacrylated type-I collagen as a dynamic, photoactive hydrogel. Biointerphases 2012, 7:1-9.
12. Du Y., Lo E., Ali S., Khademhosseini A. Directed assembly of cell-laden microgels for fabrication of 3D tissue constructs. Proc Natl Acad Sci U S A 2008, 105:9522-9527.
13. Du Y., Ghodousi M., Qi H., Haas N., Xiao W., Khademhosseini A. Sequential assembly of cell-laden hydrogel constructs to engineer vascular-like microchannels. Biotechnol Bioeng 2011, 108:1693-1703.
14. Ifkovits J.L., Burdick J.A. Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng 2007, 13:2369-2385.
15. Orive G., Maria Hernández R., Rodriguez Gascón A., Calafiore R., Swi Chang T.M., de Vos P., et al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol 2004, 22:87-92.
16. Sakai S., Mu C., Kawabata K., Hashimoto I., Kawakami K. Biocompatibility of subsieve-size capsules versus conventional-size microcapsules. J Biomed Mater Res 2006, 78A:394-398.
17. Jeon O., Alsberg E. Regulation of stem cell fate in a three-dimensional micropatterned dual-crosslinked hydrogel system. Adv Funct Mater 2013, 23:4765-4775.
18. Khetan S., Guvendiren M., Legant W.R., Cohen D.M., Chen C.S., Burdick J.A. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels. Nat Mater 2013, 12:458-465.
19. Almany L., Seliktar D. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 2005, 26:2467-2477.
20. Chiu H.-C., Hsiue G.-H., Lee Y.-P., Huang L.-W. Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system. J Biomater Sci. Polym Ed 1999, 10:591-608.
21. Two new staining procedures for quantitative estimation of proteins on electrophoretic strips. Biochim Biophys Acta 1963, 71:377-391.
22. Collin E.C., Grad S., Zeugolis D.I., Vinatier C.S., Clouet J.R., Guicheux J.J., et al. An injectable vehicle for nucleus pulposus cell-based therapy. Biomaterials 2011, 32:2862-2870.
23. Raeber G.P., Lutolf M.P., Hubbell J.A. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 2005, 89:1374-1388.
24. Fukai F., Mashimo M., Akiyama K., Goto T., Tanuma S.-I., Katayama T. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp Cell Res 1998, 242:92-99.
25. Grossmann J. Molecular mechanisms of detachment-induced apoptosis-Anoikis. Apoptosis 2002, 7:247-260.
26. Cooke M.J., Vulic K., Shoichet M.S. Design of biomaterials to enhance stem cell survival when transplanted into the damaged central nervous system. Soft Matter 2010, 6:4988.
27. Luo Y., Shoichet M.S. A photolabile hydrogel for guided three-dimensional cell growth and migration. Nat Mater 2004, 3:249-253.
28. Bianco P., Cao X., Frenette P.S., Mao J.J., Robey P.G., Simmons P.J., et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 2013, 19:35-42.
29. Au P., Tam J., Fukumura D., Jain R.K. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008, 111:4551-4558.
30. Brenes R.A., Jadlowiec C.C., Bear M., Hashim P., Protack C.D., Li X., et al. Toward a mouse model of hind limb ischemia to test therapeutic angiogenesis. J Vasc Surg 2012, 56:1669-1679.
31. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., Isner J.M. Mouse model of angiogenesis. Am J Pathol 1998, 152:1667-1679.
32. Collagen- vs Gelatine-based biomaterials and their biocompatibility: review and perspectives biomaterials: applications for nanomedicine 2011, 17-58. InTech, Rijeka, Croatia. R. Pignatello (Ed.).
33. Miller J.S., Stevens K.R., Yang M.T., Baker B.M., Nguyen D.T., Cohen D.M., et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater 2012, 11:768-774.
34. Davis K.A., Burdick J.A., Anseth K.S. Photoinitiated crosslinked degradable copolymer networks for tissue engineering applications. Biomaterials 2003, 24:2485-2495.
35. Annabi N., Nichol J.W., Zhong X., Ji C., Koshy S., Khademhosseini A., et al. Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng Part B Rev 2010, 16:371-383.
36. Pittenger M.F. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
37. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
38. Shapiro S.D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998, 10:602-608.
39. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395.
40. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374.
41. Watt F.M., Huck W.T.S. Role of the extracellular matrix in regulating stem cell fate. Nat Rev Mol Cell Biol 2013, 14:467-473.
42. Nakayama K.H., Hou L., Huang N.F. Role of extracellular matrix signaling cues in modulating cell fate commitment for cardiovascular tissue engineering. Adv Healthc Mater 2014, 3:628-641.
43. Murphy M.B., Moncivais K., Caplan A.I. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013, 45:e54.
44. Liao D., Johnson R.S. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007, 26:281-290.
45. Leroux L., Descamps B., Tojais N.F., Séguy B., Oses P., Moreau C., et al. Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a wnt4-dependent pathway. Mol Ther 2009, 18:1545-1552.
46. Kelly B.D. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003, 93:1074-1081.
47. Synergistic effect of HIF-1 gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci U S A 2009, 106:20399-20404.
48. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
49. Lin C.-C., Anseth K.S. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 2008, 26:631-643.
50. Kim S.H., Turnbull J., Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 2011, 209:139-151.
51. Zhang J., Ding L., Zhao Y., Sun W., Chen B., Lin H., et al. Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction. Circulation 2009, 119:1776-1784.